论文部分内容阅读
或许今天肾脏病学者面临的最困难的临床决策是他们的老年晚期CKD患者(年龄>70岁)是否有可能从透析治疗中受益。澳大利亚的所有透析患者中,超过65岁的患者占50%,75岁以上的患者占26%。同样,在美国年龄超过75岁的透析群增长最快,在英国增长最快的透析群则是超过65岁。不幸的是,老年透析患者的生存期通常比大多数癌症患者都要差。晚期CKD老年非透析患者,在生存、症状负担和生活质量方面的状态尚未确定。最近澳大利亚学者对采用非透析支持疗
Perhaps the most difficult clinical decision for nephrologists today is whether their elder patients with advanced CKD (age> 70 years) are likely to benefit from dialysis. Of all dialysis patients in Australia, 50% are over the age of 65 and 26% are over the age of 75. Similarly, the fastest-growing dialysis population in the United States over the age of 75 and the fastest-growing dialysis population in the UK were over 65. Unfortunately, elderly dialysis patients usually have worse survival than most cancer patients. Advanced non-dialysis CKD elderly patients, the status of survival, burden of symptoms and quality of life has not yet been determined. Recently, Australian scholars on the use of non-dialysis support therapy